Abstract
Just 100 years ago Crum-Brown and Fraser [1], in stating their conviction that biological activity must in some way be related to the structure of the agent causing it, laid the basis for all subsequent work on structure-activity relationships (S.A.R.).
Portions of this work were presented at the VII Congress of Pharmaceutical Sciences, Morelia, Mich., 13–16 November 1974
Work performed while on Sabbatical Leave at the Pharmacological Institute, University of Nijmegen, IV 1973 – III 1974
Constitutes part of the D.Sc. Thesis of J.F.R. de M., ‘Specificity in Drug Protein Interaction-Thermodynamic, Kinetic and Stereochemical Aspects’, Nijmegen 1975
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
A. Crum-Brown and T. Fraser, On the Connection between Chemical Constitution and Physiological Action, Trans. R. Soc., Edinburgh 25, 151–155 (1869).
C. Hansch, Quantitative Approaches to Pharmacological Structure-Activity Relationships, in: Structure-Activity Relationships, International Encyclopedia of Pharmacology and Therapeutics, section 5, Vol. 1 (Ed. C.J. Cavallito; Pergamon Press, Oxford 1973 ), p. 75–165.
J. Parascandola, The Evolution of Stereochemical Concepts in Pharmacology, in: The van’t Hoff-Le Bel Centennial (Ed. O.B. Ramsay; A.C.S. Symposium Series, No. 12, 1975 ).
A.R. Cushny, Biological Relations of Optically Isomeric Substances ( Williams and Wilkins, Baltimore 1926 ).
A.H. Beckett, Stereochemical Factors in Biological Activity, Prog. Drug Res. 1, 455–530 (1959).
R. Bentley, Molecular Asymmetry in Biology, Vol.1 and II (Academic Press, 1969, 1970 ).
V. Plouvier, Enantiomorphisme et racémisation chez quelques constituants végétaux, Phytochemistry 5, 955–967 (1966).
J. Weyer, A Hundred Years of Stereochemistry — The Principal Development Phases in Retrospect, Angew. Chem. Int. Edit. 13, 591–598 (1974).
P. Rona and R. Ammon, Die stereochemische Spezifität der Esterasen und die synthetisierende Wirkung der esterspaltenden Fermente, Ergeb. Enzymforsch. 2, 50–73 (1933).
W. Alworth, Stereochemistry and its Application in Biochemistry ( Wiley-Interscience, New York 1972 ).
K.R. Hanson, Enzyme Symmetry and Enzyme Stereospeciflcity, Ann. Rev. Pl. Physiol. 23, 335–366 (1972).
C.C. Pfeiffer and E.H. Jenney, Natural Asymmetry, Isomerism and Pharmacological Action, J. Sci. Ind. Res. 26, 29–34 (1967).
P.S. Portoghese, Relationships between Stereostructure and Pharmacological Activities, Ann. Rev. Pharmac. 10, 51–76 (1970).
P.N. Patil, D.D. Miller and U. Trendelenburg, Molecular Geometry and Adrenergic Drug Activity, Pharmac. Rev. 26, 323–392 (1974).
A.F. Casy, Stereochemical Aspects of Parasympathomimetics and Their Antagonists: Recent Developments, Progr. Med. Chem. 11, 1–65 (1975).
B.W.J. Ellenbroek, R.J.F. Nivard, J.M. van Rossum and E.J. Ariëns, J. Pharm. Pharmac. 17, 393–404 (1965).
B.V. Rama Sastry, Ann. Rev. Pharmac. 13, 253–267 (1973).
K.-J. Chang and D.J. Triggle, J. Med. Chem. 16, 718–720 (1973).
J.M. van Rossum, X Pharm. Pharmac. 17, 202–216 (1965).
R.R. Ison, F.M. Franks and K.S. Soh, J. Pharm. Pharmac. 25, 887–894 (1973).
B.F. Tullar, L.S. Harris, R.L. Perry, A.K. Pierson, A.E. Soria, W.F. Wetterau and N.F. Albertson, J. Med. Chem. 10, 383–386 (1967).
A. Jönsson, in: Handbuch der Pflanzenphysiologie, Vol. 14 (Ed. W. Ruhland; Springer Verlag, Heidelberg 1961 ) p. 999–1001.
B. Aberg, in: Plant Growth Regulation, International Conference, 4th ed. ( Yonkers, N.Y., 1961 ), p. 219–232.
R.B. Barlow, F.M. Franks and J.D. M. Pearson, J. Med. Chem. 16, 439–446 (1973).
H. Biere, C. Rufer, H. Ahrens, O. Loge and E. Schröder, J. Med. Chem. 17, 716–721 (1974).
C. Rufer, H. Biere, H. Ahrens, O. Loge and E. Schröder, J. Med. Chem. 17, 708–715 (1974).
R.F. Rekker, H. Timmerman, A.F. Harms and W.Th. Nauta, Arzneimittelforschung 21, 688–691 (1971).
F.P. Luduena, L. von Euler, B.F. Tullar and A.M. Lands, Arch. int. Pharmacodyn. III, 392–400 (1957).
R. Bentley, Molecular Asymmetry in Biology, Vol. 1 ( Academic Press, New York 1969 ), p. 251.
R.B. Barlow, J. Med. Chem. 16, 1037–1038 (1973).
M.A. Iorio, G. Damia and A.F. Casy, J. Med. Chem. 16, 592–595 (1973).
R.W. Brimblecombe, D.M. Green, T.D. Inch and P.B.J. Thompson, J. Pharm. Pharmac. 23, 745–757 (1971).
A.J. Beld, unpublished data.
B. Belleau and J.L. Lavoie, Can. J. Biochem. 46, 1397–1409 (1968).
J.S. de Graaf, Thesis (Leiden 1970); cf. Ree. Trav. Chim. Pays-Bas 90, 301–303 (1971).
M. Zaoral, J. Kolc and F. Sorm, Coll. Czech. Chem. Comm. 35, 1716–1726 (1970).
M.W. Monahan, M.S. Amoss, H.A. Anderson and W. Vale, Biochemistry 12, 4616–4620 (1973).
D.W. Wylie, J. Pharmac. exp. Ther. 127, 276–280 (1959).
A.F. Casy, in: Medicinal Chemistry, 3rd ed., Vol. 1 (Ed. A. Burger; Wiley-Interscience, New York 1970 ), p. 91.
A.F. Casy, in: Medicinal Chemistry, 3rd. ed., Vol. 1, (Ed. A. Burger; Wiley-Interscience, New York 1970 ), p. 94.
D.C. Dyer, D.E. Nichols, R.B. Rusterholz and C.F. Barfknecht, Life Sci. 13, 885–896 (1973).
D.T. Witiak, S.K. Seth, E.R. Baizman, S.L. Weibel and H.H. Wolf, J. Med. Chem. 15, 1117–1123 (1972).
V.P. Shah and R. Ketcham, J. Med. Chem. 7, 614–619 (1964).
R.B. Barlow, J. Pharm. Pharmac. 23, 90–97 (1971).
V.G. Daniels, H. Newey and D.H. Smith, Biochim. biophys. Acta 183, 637–639 (1969).
D.F. Biggs, A.F. Casy and W.K. Jeffery, J. Med. Chem. 15, 506–509 (1972).
H.P. Büch, F. Schneider-Affeld, W. Rummel and J. Knabe, Naunyn- Schmiedebergs Arch. Pharmac. 277, 191–198 (1973).
P.N. Patil, J.B. La Pidus, D. Campbell and A. Tye, J. Pharmac. exp. Ther. 155, 13–23 (1967).
J. Besse and R. Furchgott, Fed. Proc. 26, 401 (1967).
A.F. Casy, in: Medicinal Chemistry, 3rd ed., Vol. 1 (Ed. A. Burger; Wiley-Interscience, New York 1970 ), p. 99.
K.J. Chang, R.C. Deth and D.J. Triggle, J. Med. Chem. 15, 243–247 (1972).
A.F. Casy, in: Medicinal Chemistry, 3rd ed., Vol. 1 (Ed. A. Burger; Wiley-Interscience, New York 1970 ), p. 89.
K.H. Bell and P.S. Portoghese, J. Med. Chem. 16, 589–591 (1973).
E. Havinga, C. Schattenkerk, G. Heymens-Visser and K.E.T. Kerling, Ree. Trav. Chim. Pays-Bas 83, 672–676 (1964), and 84, 653–658 (1965).
J.R.E. Hoover, G.L. Dunn, D.R. Jakas, L.L. Lam, J.J. Taggart, J.R. Guarini and L. Phillips, J. Med. Chem. 17, 34–41 (1974).
A.M. Asatoor, A. Chadha, M.D. Melne and D.I. Prosser, Clin. Sei. molee. Med. 45, 199–212 (1973).
N.B. Eddy, E.L. May and E. Mosettig, J. Org. Chem. 17, 321–326 (1952).
T.D. Inch and R.W. Brimblecombe, J. Pharm. Pharmac. 23, 813–815 (1971).
A. Hassan and W.C. Dauterman, Biochem. Pharmac. 17, 1431–1439 (1968).
A.H. Beckett, N.J. Harper, J.W. Clitherow and E. Lesser, Nature, Lond. 189, 671–673 (1961).
A. Morello, E.Y. Spencer and A. Vardanis, Biochem. Pharmac. 16, 1703–1710 (1967).
M.W. Anders, M.J. Cooper and A.E. Takemori, Drug Metab. Disp. 1, 642–644 (1973).
K.K. Chen, C.K.Wu and E. Henriksen, J. Pharmac. exp. Ther. 36, 363–401 (1929).
C.M. Kagawa and M.J. Kalm, Arch. int. Pharmacodyn. 137, 241–249 (1962).
R.W. Brimblecombe and T.D. Inch, J. Pharm. Pharmac. 22, 881–888 (1970).
H. Ott, G.E. Hardtmann, M. Denzer, A.J. Frey, J.H. Gogerty, G.H. Leslie and J.H. Trapold, J. Med. Chem. 11, 777–787 (1968).
A. J. J. Ooms and H.L. Boter, Ree. Trav. Chim. Pays-Bas 86, 399–404 (1967), as modified and extended in a personal communication.
Y. Hayashi and W.B. Lawson, J. biol. Chem. 244, 4158–4167 (1969).
T.N. Pattabiraman and W.B. Lawson, Biochem. J. 126, 645–657 (1972).
T.N. Pattaberaman and W.B. Lawson, Biochem. J. 126, 659–665 (1972).
T.N. Pattabiraman and W.B. Lawson, J. biol. Chem. 247, 3029–3038 (1972).
S.J. Fu, S.M. Birnbaum and J.P. Greenstein, J. Am. Chem. Soc. 76, 6054–6058 (1954).
J.-J. Bechet, A. Dupaxx and C. Roucous, Biochemistry 12, 2566–2572 (1973).
N. Abramowitz, I. Schechter and A. Berger, Biochem. biophys. Res. Comm. 29, 862–867 (1967).
J.R. Rapp, C. Niemann and G.E. Hein, Biochemistry 5, 4100–4105 (1966).
A.J.J. Ooms and H.L. Boter, Biochem. Pharmac. 14, 1839–1846 (1965).
M.A. Iorio, H. Michalek and S. Chiaverelli, Molec. Pharmac. 5, 580–583 (1969).
M. Winitz, L. Bloch-Frankenthal, N. Izumiya, S. Birnbaum, C.G. Baker and J. P. Greenstein, J. Am. Chem. Soc. 78, 2423–2430 (1956).
H.L. Boter and A.J.J. Ooms, Biochem. Pharmac. 16, 1563–1569 (1967).
D.S. Robinson, S.M. Birnbaum and J.P. Greenstein, J. biol. Chem. 202, 1–26 (1953).
A. Meister, Fed. Proc. 27, 100–109 (1968).
R.F. Shonk, D.D. Miller and D.R. Feller, Biochem. Pharmac. 20, 3403–3412 (1971).
D.W. Ingles and J.R. Knowles, Biochem. J. 104, 369–377 (1967).
R. Marshall, S.M. Birnbaum and J.P. Greenstein, J. Am. Chem. Soc. 78, 4636–4642 (1956).
H.J. Schaeffer, R.N. Johnson, M.A. Schwartz and C.F. Schwender, J. Med. Chem. 15, 456–458 (1972).
E.L. Smith, N.C. Davis, E. Adams and D.H. Spackman, in: The Mechanism of Enzyme Action (Eds. W.D. McElroy and B. Glass; The Johns Hopkins Press, Baltimore 1954 ), p. 291.
M.A. Raftery, F.W. Dahlquist, S.M. Parsons and R.G. Wolcott, Proc. Nat. Acad. Sci., USA 62, 44–51 (1969).
B.E. Leach and R.J. Angelici, J. Am. Chem. Soc. 91, 6296–6300 (1969).
G. Werner and G. Brehmer, Hoppe-Seyler’s Z. physiol. Chem. 348, 1640–1652 (1967).
S.F. Contractor and J. Wragg, Nature 208, 71–72 (1965).
A. H. Beckett and P. Anderson, J. Pharm. Pharmac. 12, Suppl., 228T–236T (1960).
A.H. Beckett, C.L. Vaughan and M. Mitchard, J. Med. Chem. 11, 1126–1129 (1968).
R. L. Heinrikson, J. biol. Chem. 241, 1393–1405 (1966).
L.D. Rumsh, L.I. Volkova and V.K. Antonov, FEBS Lett. 9, 64–66 (1970).
H.H.W. Thussen, Thesis (Nijmegen 1973 ).
W.S. Fones and M. Lee, J. biol. Chem. 201, 847–856 (1953).
A. H. Beckett and P. Anderson, Nature 179, 1074–1075 (1957).
F.J. Dale and B. Robinson, J. Pharm. Pharmac. 22, 889–896 (1970).
A. H. Beckett, Progr. Drug Res. 1, 455–530 (1959).
R. Bentley, in: Molecular Asymmetry in Biology, Vol.1 and 2 (Academic Press, New York 1969 and 1970 ).
W.L. Alworth, Stereochemistry and Its Application in Biochemistry ( Wiley- Interscience, New York 1972 ).
A.F. Casy, in: Medicinal Chemistry, 3rd ed., Vol. 1 (Ed. A. Burger; Wiley-Interscience, New York 1970 ), p. 81–107.
P.S. Portoghese, Ann. Rev. Pharmac. 10, 51–76 (1970).
P.N. Patel and J.B. La Pidus, Ergeb. Physiol. 66, 213–260 (1972).
C.C. Pfeiffer, Science 124, 29–31 (1956).
E.J. Ariëns and A.M. Simonis, Ann. N.Y. Acad. Sci. 144, 842–868 (1967).
E. A. Zeller, Ann. N.Y. Acad. Sci. 107, 811–821 (1963).
F.G. van den Brink, Thesis (Nijmegen 1969), p. 119–125.
L. Pasteur, C. r. Sci., Paris 46, 615 (1858), and 51, 298 (1860).
A. Piutti, C. r. Sci., Paris 103, 134 (1886).
L. Pasteur, Recherches sur la Dissymétrie Moléculaire des Produits Organiques Naturels (Paris 1861 ).
A. H. Beckett, Progr. Drug Res. 1, 455–530 (1959).
P. Rona and R. Ammon, Ergeb. Enzymforsch. 2, 50–73 (1933).
L.H. Easson and E. Stedman, Biochem. J. 27, 1257–1266 (1933).
C.L. Hamilton, C. Niemann and G.S. Hammond, Proc. Nat. Acad. Sci., USA 55, 664–669 (1966).
C.C. Pfeiffer, Science 124, 29–31 (1956).
E.J. Ariëns and A.M. Simonis, Ann. N.Y. Acad. Sci. 144, 842–868 (1967).
E.J. Ariëns, in: Drug Design, Vol. I, (Ed. E.J. Ariens; Academic Press, New York, N.Y., 1971), p. 150, 182.
C.C. Pfeiffer and E.H. Jenney, J. Sci. Ind. Res. 26, 29–34 (1967).
L.P. Hammett, in: Physical Organic Chemistry (McGraw-Hill Book Co., Inc., New York, N.Y., 1940), p. 184–190, 222.
R.W. Taft, Jr., J. Am. Chem. Soc. 74, 2729–2732 (1952).
C. Hansch, R.M. Muir, T. Fujita, P.P. Maloney, F. Geiger and M. Streich, J. Am. Chem. Soc. 85, 2817–2824 (1963).
C. Hansch, Quantitative Approaches to Pharmacological Structure-Activity Relationships, in: Structure-Activity Relationships, International Encyclopedia of Pharmacology and Therapeutics, section 5, Vol. 1 (Ed. C.J. Cavallito; Pergamon Press, Oxford 1973 ), p. 75–166.
E.J. Lien, J.F. Rodrigues de Miranda and E.J. Ariëns, Molec. Pharmac. (in press).
A.S.V. Burgen, J. Pharm. Pharmac. 18, 137–149 (1965).
P.W. Taylor, R.W. King and A.S.V. Burgen, Biochemistry 9, 2638–2645 (1970).
J.F. Rodrigues de Miranda and C.W. Hilbers, Molec. Pharmac. 12, 279–290 (1976).
J. Engel and D. Winklmair, in: Protein-Protein Interactions, 23. Colloquium der Gesellschaft für Biologische Chemie, Mosbach, Baden 1972 (Eds. R. Jaenicke and E. Helmreich; Springer-Verlag, Berlin 1972 ), p. 159–181.
M. Eigen and D. Pörschke, J. Mol. Biol. 53, 123–141 (1970).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1976 Birkhäuser Verlag, Basel
About this chapter
Cite this chapter
Lehmann F., P.A., Rodrigues de Miranda, J.F., Ariëns, E.J. (1976). Stereoselectivity and Affinity in Molecular Pharmacology. In: Jucker, E. (eds) Progress in Drug Research/Fortschritte der Arzneimittelforschung/Progrés des recherches pharmaceutiques. Progress in Drug Research/Fortschritte der Arzneimittelforschung/Progrés des recherches pharmaceutiques, vol 20. Birkhäuser Basel. https://doi.org/10.1007/978-3-0348-7094-8_4
Download citation
DOI: https://doi.org/10.1007/978-3-0348-7094-8_4
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-0348-7096-2
Online ISBN: 978-3-0348-7094-8
eBook Packages: Springer Book Archive